We propose a standardized medicinal plant raw material (MPRM) for the needs of pharmaceutical and processing enterprises in accordance with GACP requirements. We also propose standardized plant extracts and ether oils by the CO2 extraction method for pharmaceutical, cosmetic and food companies at a competitive price.

1. INVESTMENT PROJECT v4.00 – +38 044 247 9301 - www.shlosem.com -office@shlosem.com-UKRAINE – 14.03.2018
4th year
55ths $ 12 %
3rd year
1890ths $ 42%
2nd year
2088ths $ 47%
1st year
457ths $ 11%
SCHLOSEM UKRAINA, LTD. INNOVATIVE AGRO-INDUSTRIAL COMPLEX FOR THE CULTIVATION,
PREPARATION AND PROCESSING OF MEDICINAL PLANT RAW MATERIALS
We propose a standardized medicinal plant raw material (MPRM) for the needs of
pharmaceutical and processing enterprises in accordance with GACP requirements.
We also propose standardized plant extracts and ether oils by the CO2 extraction method for
pharmaceutical, cosmetic and food companies at a competitive price.
OUR INGENUITY IS YOUR OPPORTUNITY
PROBLEMS THAT NEED SOLUTIONS:
Insufficiency of standardized medicinal plant raw materials;
Lack of information about the origin and processing;
High price of standardized plant extracts
OUR SOLUTION:
We apply in our production process GACP and ISO 9001:2004 standards as a guarantee of
the stable quality of our product and thanks to medicinal plant raw materials produced in-
house we also can propose competitive prices for plant extracts and ether oils.
TARGET MARKET:
The world market for medicinal plants is estimated at US $ 1.2 bn
(600,000 tons);¹
The market for herbal products throughout the world is currently
worth around an estimated US $60 bn per year with a CAGR of 7.0%;²
The world ginseng market including ginseng root and the processed
products, is estimated to be worth US $2.1bn (80 ths. ton);³
The global market of plant extracts is estimated to US $79.2bn at a
CAGR of 11.4% during the forecast period.⁴
THE COMPETITION:
GROUP COMPANY OUR ADVANTAGES
Agro-firms that
cultivate MPRM
Phytocom, Phytosvit,
Raiduha, Rostok
Standardization of production
processes, GACP
Extract production
companies
Martin Bauer, Flavex,
Grumextract
Low production costs labor, own
raw materials)
Wholesale companies
that sell MPRM
Sumyfitomarmatsiy,
Еlpis
Own production, certification
GACP, ISO 9001:2004
Companies that
cultivate ginseng
Baumann, Imperial
Ginseng, HsuGinseng
Low production costs (labor,
seeds)
SALES AND MARKETING
SALES CHANNELS:
Direct sales: pharmaceutical, cosmetic, perfume and food companies;
Indirect sales: selective dealers and independent trading agents.
MARKETING ACTIVITIES:
Visitations to key clients, telephone calls, catalog send-outs;
Exhibition activity at specialized local and international exhibitions;
Participation in specialized sector-based conferences.
REVENUES (ths $): EXPENSES:
MILESTONES:
THREATS:
 Technology
implementation risks;
 Profitability risks;
 Market risks;
 Shortage of qualified
manpower.
PROJECT INVESTMENT
ATTRACTIVENESS:
DPP, years – 6,92
NPV, ths $ – 71
IRR, % – 17,1
PI – 1,02
Item, ths UAH 1 year 2 year 3 year 4 year 5 year 6 year 7 year
Total Revenues 328 820 4 363 6 372 6 719 7 027 7 270
Gross Profit 154 268 2 059 3 303 3 474 3 628 3 739
Gross profit Margin (%) 47% 33% 47% 52% 52% 52% 51%
EBITDA -17 -91 1 531 2 726 2 866 2 987 3 064
EBITDA Margin -5% -11% 35% 43% 43% 43% 42%
EBIT -23 -155 1 323 2 491 2 657 2 779 2 856
Ordinary Income Margin -7% -19% 30% 39% 40% 40% 39%
Net Profit / Loss -65 -280 971 1 984 2 179 2 279 2 342
Return on sales (%) -20% -34% 22% 31% 32% 32% 32%
REQUIRED
INVESTMENTS
US$ 4 490k
INVESTMENT EXPENDITURES: PROJECT INVESTMENT EXPENDITURES:
TEAM AND KEY ROLES:
Roman Mykhailych – Director of Marketing – 12 years of experience in
management;
Vasyl Pachovskyy – – Project Manager/Director of Production Operations - 8
years in project management in the sphere of MPRM and plant extracts;
Alexander Gubanev – Cultivation consultant – 35 years of experience in
medicinal plant cultivation, introduction of many forms of medicinal plant;
Olha Yaruta – Cultivation specialist – 8 years of experience of scientific and
practical work in the sphere of plant cultivation.
PARTNERS AND RESOURCES:
Medicinal plant research station – Seeds and MPRM cultivation technology;
The Ontario Ginseng Growers Association – Seeds and gensing cultivation
technology;
State Quality Laboratory – Analysis of soils, water and plant raw materials;
Natex – Equipment for СО2 extraction and service, extraction technology;
Flavex – Medicinal plant extraction technology, quality standards;
“Ukrmetrteststandart” state enterprise - ISO 9001, ISO 14001, ISO 22000
certification.
¹ Medicinal and Aromatic Plants: Trade, Production, and Management of Botanical Resources. Dagmar Lange University of Landau, Institute of Biology. Im Fort 7, D-76829 Landau, Germany.
² Herbal medicine research and global health: an ethical analysis. Jon C Tilburt and Ted J Kaptchuk. Bull World Health Organ. 2008 Aug; 86(8): 594–599. doi: 10.2471/BLT.07.042820.
³ The world ginseng market and the ginseng. In-Ho Baeg and Seung-Ho So. J Ginseng Res Vol. 37, No. 1, 1-7 (2013). http://dx.doi.org/10.5142/jgr.2013.37.1
⁴ Plant Extracts Market: By Type (Phytochemicals, Essential Oils, Oleoresins, Others) By Form (Powdered, Liquid, Others) End-Use Industry (Nutraceuticals, Cosmoceuticals, Functional Food & Beverage and Pharmaceuticals) & By Geography-Forecast(2015-2020).
0
1 000
2 000
3 000
4 000
5 000
1st year 2nd year 3rd year 4th year 5h year 6h year 7h year
Medical and aromatic herbs CO2 extracts
73%
16%
6%
3% 2%
Raw materials
Salary
Production costs
General expenses
Marketing expenses
Project initiation
(1.2.18 -23.03.18)
Planning process
(24.03.18 -06.07.18)
Preparation for production
(09.07.18-01.03.19) - 1 phase
(01.07.19-07.02.20) - 2 phase
Production
(from 01.10.18 - Medical and aromatic herbs)
(from 01.03.20 - СО2 extracts)
6,7%
16,3%
74,1%
1,6%
0,0% 1,3%
Land, 500 ha
Buildings and structures
Equipment and other assets
Intangible assets
Financial assets
Deferred expenses